Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs
Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Regulatory Rapporteur - December 2025
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • Artificial intelligence
    • ATMP
    • Biologics
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Oncology
    • Product information
    • Regulatory procedures
  • Veterinary
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
    • Artificial intelligence
  • Industry news
    • Back to parent navigation item
    • Industry news
    • Industry news
      • Back to parent navigation item
      • Industry news
      • Read latest news
      • Video
  • Commentary
    • Back to parent navigation item
    • Commentary
    • Editorials
    • Letters to the Editor
    • Podcasts
  • Collections
    • Back to parent navigation item
    • Collections
    • Interviews
    • Symposium 2024
      • Back to parent navigation item
      • Symposium 2024
      • Annual lecture
    • Symposium 2023
      • Back to parent navigation item
      • Symposium 2023
      • Annual lecture
    • Symposium 2022
      • Back to parent navigation item
      • Symposium 2022
      • Annual lecture
    • Regulatory Careers Live
    • CPD supplements
      • Back to parent navigation item
      • CPD supplements
      • 2021/2022
      • 2020
      • 2019
    • Symposium 2021
      • Back to parent navigation item
      • Symposium 2021
      • Annual lecture
  • JOIN TOPRA
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs
  • Regulatory Rapporteur - December 2025
  • Pharmaceuticals
      • Artificial intelligence
      • ATMP
      • Biologics
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Oncology
      • Product information
      • Regulatory procedures
    • AdobeStock_521699095
      A year of change for the US FDA: An update on notable pilots and programmes
    • Half page-REGRAP-ISSUE 22-11-December 2025
      Regulatory Rapporteur December 2025 – Contents
    • Editorial
      North America: Transparency, transformation and innovation pathways
  • Veterinary
    • Jana Schalansky
      November 2025 – Contents: Veterinary medicines sessions
    • RR-June-2025-half cover _masthead
      June 2025 – Contents
    • June cover image licensed
      Veterinary medicines: Translating regulation into practice
    • RR-Nov-2024-Half-Cover
      November 2024 – Contents: Veterinary medicines sessions
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
      • Artificial intelligence
    • EQUITY image for online
      Bridging the digital divide: A toolkit for equity-centred regulation of digital mental health
    • Ashleigh Batchen
      November 2025 – Contents: Medical devices/IVD sessions
    • MDR-innovation-compressed
      The EU Medical Device Regulation: Balancing innovation with regulation
  • Industry news
      • Industry news
        • Read latest news
        • Video
    • Saudi Arabia FDA news story image 3
      Saudi FDA vision to be a leading regulator includes updating guidance on combination products
    • EC med devices news story
      EC proposes regulation to simplify rules on medical and in vitro diagnostic devices
    • Vet adverse events news image 1
      The VMD changes how it calculates adverse events incidents for animals
  • Commentary
      • Editorials
      • Letters to the Editor
      • Podcasts
    • Editorial
      North America: Transparency, transformation and innovation pathways
    • Symposium Day 2
      TOPRA Symposium 2025: Leading with impact
    • Oct issue cover licensed
      From trials to approval: Regulatory strategies in early drug development
  • Collections
      • Interviews
      • Symposium 2024
        • Annual lecture
      • Symposium 2023
        • Annual lecture
      • Symposium 2022
        • Annual lecture
      • Regulatory Careers Live
      • CPD supplements
        • 2021/2022
        • 2020
        • 2019
      • Symposium 2021
        • Annual lecture
    • Banner_new
      Streamline medical device compliance with BSI Compliance NavigatorSponsored by The UK's National Standards Body
    • AdobeStock_59790119
      The Olaratumab experience
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
  • JOIN TOPRA
  • More from navigation items
Pharmaceuticals

November 2024 – Contents

  • No comments

 

RR-Nov-2024-Half-Cover

Regulatory
Rapporteur

 

Write to the Editor at publications@topra.org

November 2024  |  Vol. 21  |  No. 10

 

EDITORIAL

Improving health outcomes through regulatory excellence

Cover option 1 MichaelKipping

READ HERE

By Kornelia Grein, Sobhey Nassar and Marie Uguen

 

HUMAN MEDICINES

Human medicines sessions

SabineHaubenreisser

READ THE SESSION SUMMARIES HERE

 

MEDICAL DEVICES/IVDS

Medical devices/IVDs sessions   

MD1 -MargarethJorvid

READ THE SESSION SUMMARIES HERE

 

VETERINARY MEDICINES

Veterinary medicines sessions

VM1 - RickClayton

READ THE SESSION SUMMARIES HERE

 

PARALLEL SESSION

PS1: Resolving specific development hurdles via scientific advice

PS1 - SandraLourenço

READ HERE

By Ophélie Poujade

 

PARALLEL SESSION

PS2: Patient experience data – The next steps towards medicines evaluation

PS2 - JuanGarciaBurgos

READ HERE

By Anna Koptina

 

SME, ACADEMIA AND START-UPS

SME: Regulatory updates for SME, academia and start-ups

SME -MarjonPasmooij

READ HERE

By Marie Uguen

 

ANNUAL LECTURE

The TOPRA annual lecture: Status of global health  

AnnualLecture - IlonaKickbusch

READ HERE

By Margareth Jorvid

 

Topics

  • 2024
  • Human medicines
  • IVD
  • Medical Devices
  • November 2024
  • Pharmaceuticals
  • Symposium 2024
  • Veterinary
  • No comments

More from Pharmaceuticals

  • NSN final image
    Journal

    From laboratory to patient: The role of New Substance Notifications in delivering innovative therapies in Canada

    2025-12-15T12:40:00Z

    By Mary Weedon, Reham Elfarmawy and Rawaa Hussain

  • Falk Ehmann
    Journal

    ​HM2: Fireside chat

    2025-11-18T09:44:00Z

    By Cristina Dragan

  • PROBIOTICS image 2
    Journal

    ​Probiotics as nutraceuticals: Bridging science, health and regulation

    2025-10-10T11:16:00Z

    By Sukesh Bhardwaj, Kirti Yadav, Vivek Tomar, Allison Gillespie, Navaneetha Vallala and Anil Kumar M

  • ODD licensed image (2)
    Journal

    ​The importance of patient advocacy in the EMA ODD process

    2025-07-11T10:22:00Z

    By Catherine Moncad

  • EUPATI licensed image
    Journal

    Patient involvement in the regulatory area: Insights into national level dialogues

    2025-07-11T10:22:00Z

    By Maria Dutarte and Birka Lehmann

  • PPI licensed image
    Journal

    ​The evolving landscape of public and patient involvement

    2025-07-11T10:21:00Z

    By Mandy Daly

Related articles

  • Half page-REGRAP-ISSUE 22-11-December 2025
    Contents

    Regulatory Rapporteur December 2025 – Contents

  • Editorial
    Editorial

    North America: Transparency, transformation and innovation pathways

    2025-12-11T12:01:00Z

    By Leah R. Kleylein

  • Antonella Lombardi and Carlos Galamba
    Journal

    IVD8: The hunt for evidence – An IVD perspective

    2025-11-18T10:15:00Z

    By Margareth Jorvid

  • Alex Laan_IVD7
    Journal

    IVD7: EU reference laboratories under the IVDR – One year on

    2025-11-18T10:14:00Z

    By ​Claire McDonald

  • Jana Schalansky
    Contents

    November 2025 – Contents: Veterinary medicines sessions

  • Ashleigh Batchen
    Contents

    November 2025 – Contents: Medical devices/IVD sessions

No comments yet

You're not signed in.

Only registered users can comment on this article.

Sign in Register
  • What is Regulatory Affairs?
  • TOPRA Membership
  • Regulatory Rapporteur Editorial Board
  • Regulatory Rapporteur Editorial Area
  • Future Focus Topics
  • FAQs
  • Glossary
  • Privacy Policy
  • ISSN 2755-5070 (online)

    ISSN 1742-8955 (print - legacy)

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, Third floor, City Reach, 5 Greenwich View Place, London E14 9NN, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70

  • Contact us
  • Copyright © 2015-2025 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved

Site powered by Webvision Cloud